The Trudeau government will likely expand the scope of our public health-care system and Canadian families will pay even more for public health care every year.
The province spent more per-capita on health care than any other province.
In 2017, the federal government introduced new regulations for the drug review board.
Advanced clinical trials in Canada, which were consistent between 2015 and 2019, decreased by 26 per cent in 2020.
New drugs are approved later in Canada than in the United States and European Union.
Regardless of their potential impact on patient health, drug approval times in Canada were longer than in other countries.
The province had the capacity to perform more than 1.3 million CT exams but only 419,000 were actually performed.
Hospitals currently view patients as costs that eat into the budget.
Drugs were approved in the U.S. 469 days earlier (on average) than in Canada.
The elective surgery queue cost 1.2 million Canadians a total of $2.8 billion in lost wages and productivity.
Subscribe to the Fraser Institute
Get the latest news from the Fraser Institute on the latest research studies, news and events.